INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

For the key trials, our articles and recipes, read the Cancer Risk Reduction desk →

1,241 studies · page 44 of 52

2019 / Randomized, placebo-controlled, 2x2 factorial trial

Supplementation with marine n-3 fatty acids did not reduce the incidence of major cardiovascular events or invasive cancer compared with placebo.

In the VITAL trial, 25,871 participants were randomized to 1 g per day of marine n-3 fatty acids or placebo (alongside vitamin D3 in a 2x2 factorial design) with a median follow-up of 5.3 years. Marine n-3 fatty acid supplementation did not significantly lower major cardiovascular events (HR, 0.92; 95% CI, 0.80 to 1.06; P=0.24) or invasive cancer (HR, 1.03; 95% CI, 0.93 to 1.13; P=0.56). For secondary endpoints, total myocardial infarction was lower in the n-3 group (HR, 0.72; 95% CI, 0.59 to 0.90), but stroke, cancer death, and all-cause death showed no significant differences. No excess risks of bleeding or other serious adverse events were observed.

Manson JE, Cook NR, Lee IM, et al. N Engl J Med, 2019. PMID 30415637

2019 / Two-arm randomized clinical trial

A 12-week dietary counseling intervention to increase cruciferous and green leafy vegetables was feasible in head and neck cancer survivors.

A 12-week pilot RCT evaluated the feasibility of telephone dietary counseling to increase cruciferous (CV) and green leafy vegetable (GLV) intake in 24 posttreatment head and neck cancer survivors. The study had an enrollment rate of 25% (24 of 98 eligible) and a 96% retention rate. Adherence rates to weekly goals were 67% for CV, 74% for GLV, and 71% overall, with the intervention group increasing intake by a mean of 5.5 cups GLV and 3.5 cups CV per week. No significant between- or within-arm differences were observed for inflammatory markers or carotenoids.

Crowder SL, Frugé AD, Douglas KG, et al. J Acad Nutr Diet, 2019. PMID 30661935

2019 / Randomized controlled trial

Beetroot juice consumption significantly increased urinary excretion of potentially carcinogenic N-nitroso compounds in healthy active adults.

In a randomized controlled trial, 29 healthy recreationally active volunteers ingested beetroot juice with or without vitamin C supplements for one week. Urinary apparent total N-nitroso compounds (ATNC) significantly increased after one dose (5 to 47 nmol/mmol, p < 0.0001) and increased further after seven consecutive doses (104 nmol/mmol, p < 0.0001). Vitamin C supplementation inhibited the ATNC increase after one dose (16 compared to 72 nmol/mmol, p < 0.01), but had no inhibitory effect after seven daily doses.

Berends JE, van den Berg LMM, Guggeis MA, et al. Int J Mol Sci, 2019. PMID 31072023

2019 / Randomized controlled trial

A low-fat dietary pattern did not reduce overall breast cancer, colorectal cancer, or CHD, but was tied to lower risks of death from breast cancer and diabetes.

The Women's Health Initiative Dietary Modification trial randomized 48,835 postmenopausal women to either a low-fat dietary pattern intervention (reducing fat to 20% of energy and increasing vegetables, fruit, and grains) or a usual-diet comparison group. Time-to-outcome analyses showed no significant differences for invasive breast cancer, colorectal cancer, or coronary heart disease (CHD) over an 8.5-year median intervention or longer-term follow-up. However, over a 19.6-year median follow-up, the intervention group had significantly lower hazards for breast cancer followed by death (HR 0.84; 95% CI: 0.74, 0.96) and diabetes requiring insulin (HR 0.87; 95% CI: 0.77, 0.98), along with other benefits related to breast cancer, CHD, and diabetes without adverse effects.

Prentice RL, Aragaki AK, Howard BV, et al. J Nutr, 2019. PMID 31175807

2019 / Randomized, placebo-controlled, multidose trial

A full-dose broccoli sprout beverage significantly increased the urinary detoxication biomarker for benzene by 63.2% in a randomized trial.

In Qidong, China, 170 subjects were randomized to consume a placebo drink (n = 55) or one of three doses of a broccoli sprout beverage—full (n = 25), one-half (n = 35), or one-fifth (n = 55)—for 10 consecutive days. Median 24-h urinary output of sulforaphane metabolites was 24.6, 10.3, and 4.3 µmol across the three doses, respectively. The high-dose group showed a statistically significant 63.2% increase in urinary benzene mercapturic acids compared with controls over the 10-day period. Changes in the one-half dose (+11.3%) and one-fifth dose (-6.4%) groups were not significantly different from placebo.

Chen JG, Johnson J, Egner P, et al. Am J Clin Nutr, 2019. PMID 31268126

2019 / Randomized controlled trial

Long-term garlic and vitamin supplementation reduced gastric cancer mortality over 22 years.

During 22 years of follow-up in 3,365 residents, garlic supplementation for 7.3 years significantly reduced gastric cancer mortality (hazard ratio 0.66, 95% CI 0.43 to 1.00), though it did not significantly reduce incidence (odds ratio 0.81, 95% CI 0.57 to 1.13). Vitamin supplementation significantly lowered both gastric cancer mortality (hazard ratio 0.48, 95% CI 0.31 to 0.75) and incidence (odds ratio 0.64, 95% CI 0.46 to 0.91).

Li WQ, Zhang JY, Ma JL, et al. BMJ, 2019. PMID 31511230

2019 / Randomized controlled trial

High drinking water nitrate levels increased the endogenous formation of apparent total N-nitroso compounds regardless of meat type consumed.

Twenty healthy volunteers were randomized to consume either processed red meat or unprocessed white meat (3.75 g/kg body weight, max 300 g/day) for two weeks, with low drinking water nitrate in week 1 (< 1.5 mg/L) and high nitrate in week 2 (3.7 mg/kg body weight). Urinary nitrate excretion and faecal ATNC levels significantly increased during the high nitrate period across both meat types, with ATNC increases being more pronounced in the processed red meat group. Faecal water genotoxicity in Caco-2 cells was significantly increased only during the low drinking water nitrate period in the processed red meat group. A positive correlation between the nitrate/vitamin C intake ratio and faecal water ATNC in the processed red meat group was not statistically significant.

van Breda SG, Mathijs K, Sági-Kiss V, et al. Environ Health, 2019. PMID 31623611

2018 / Randomized crossover trial

Short-term fasting during chemotherapy was well tolerated and reduced quality of life deterioration.

In this randomized crossover pilot trial with 34 patients undergoing chemotherapy for gynecological cancer, 60-hour fasting (36 hours before to 24 hours after treatment) was compared to a normocaloric diet. Fasting reduced chemotherapy-related declines in quality of life to below the minimally important difference. Deterioration of total FACIT-F scores was lower during fasted cycles compared to non-fasted cycles in both groups without serious adverse events.

Bauersfeld SP, Kessler CS, Wischnewsky M, et al. BMC Cancer, 2018. PMID 29699509

2018 / Randomized controlled trial

A low-fat dietary pattern increased overall survival in postmenopausal women with breast cancer

In a secondary analysis of a randomized trial among 48,835 postmenopausal women, 1,764 developed incident breast cancer during an 8.5-year dietary intervention. Post-diagnosis follow-up showed significantly higher overall survival in the low-fat dietary group compared with usual diet (10-year survival 82% vs 78%; HR, 0.78; 95% CI, 0.65-0.94; P = 0.01). The dietary group had fewer cardiovascular deaths (HR, 0.62; 95% CI, 0.39-0.99) and non-significant reductions in breast cancer mortality.

Chlebowski RT, Aragaki AK, Anderson GL, et al. JAMA Oncol, 2018. PMID 29800122

2018 / Crossover study (in human volunteers)

An antioxidant marinade reduced fecal lipid peroxidation markers from beef consumption in humans and limited carcinogenesis in rodents.

Researchers tested whether an antioxidant marinade on beef with various degrees of cooking could limit lipid peroxidation and carcinogenesis in rats, Min mice, and human volunteers in a crossover study. Fresh beef increased lipoperoxidation in humans, rats, and mice, and increased colon carcinogenesis in the rodents. Without adverse organoleptic effects, the marinade reduced peroxidation biomarkers in human feces, normalized them in rodent feces, and reduced mucin-depleted foci in rats and adenomas in female Min mice.

Martin OCB, Naud N, Taché S, et al. Cancer Prev Res (Phila), 2018. PMID 29954759

2018 / Randomized, double-blind, placebo-controlled trial

Vitamin D supplementation did not improve overall survival in NSCLC patients, but improved 5-year survival in early-stage adenocarcinoma with low vitamin D.

A randomized, double-blind trial evaluated vitamin D supplements (1,200 IU/day) versus placebo for 1 year in 155 postoperative NSCLC patients followed for a median of 3.3 years. In the total population, no significant difference was observed for RFS or OS between groups. However, among patients with early-stage adenocarcinoma and low 25(OH)D (<20 ng/mL), vitamin D supplementation led to significantly higher 5-year RFS (86% vs. 50%, P = 0.04) and OS (91% vs. 48%, P = 0.02). DBP1 TT and CDX2 AA/AG genotypes were also markers of better prognosis.

Akiba T, Morikawa T, Odaka M, et al. Clin Cancer Res, 2018. PMID 30018118

2018 / Randomized controlled crossover intervention trial

Cooked Ethiopian kale significantly reduced ex vivo aflatoxin B1-induced DNA damage, while raw kale lowered plasma PGE2 in a randomized crossover trial.

In a randomized crossover trial, 22 healthy subjects consumed preparations of raw or cooked Brassica carinata leaves for 5 days. Cooked B. carinata significantly reduced aflatoxin B1-induced DNA damage in peripheral blood mononuclear cells compared to baseline (+S9 mix: 35%, -S9 mix: 33%, p <= 0.01). Raw B. carinata reduced DNA damage from S9-activated AFB1 by 21% (p = 0.08) and significantly reduced plasma prostaglandin E2 levels. No changes were observed in plasma total antioxidant capacity.

Schlotz N, Odongo GA, Herz C, et al. Nutrients, 2018. PMID 30400138

2017 / Randomized controlled trial

Fresh yellow onion intake lowered fasting glucose and insulin resistance during breast cancer chemotherapy.

Eligible breast cancer patients receiving doxorubicin-based chemotherapy were randomized to an 8-week intervention with high daily onion intake (100 to 160 g/d) or low daily onion intake (30 to 40 g/d). Analyses of 23 participants per group revealed that high onion intake significantly decreased fasting blood glucose and insulin levels relative to low onion intake (P < .001). Post-treatment insulin resistance assessed by HOMA-IR was also significantly lower in the high onion group (P < .05).

Jafarpour-Sadegh F, Montazeri V, Adili A, et al. Integr Cancer Ther, 2017. PMID 27352956

2017 / Randomized controlled trial

Oral nicotinamide reduced actinic keratosis size and prevented new lesions in organ transplant recipients over six months.

Thirty-eight transplant recipients with actinic keratoses (AKs) were randomly assigned to receive 500 mg daily oral nicotinamide (n=19) or no nicotinamide (n=19) for six months. At baseline, AK size did not differ significantly between groups. After six months, AKs significantly decreased in size in 18 of 19 treated patients (88%), with complete clinical regression in seven patients (42%) and no new AKs. In contrast, 91% of controls showed increased AK size and/or developed new AKs, and seven pre-existing AKs progressed to squamous-cell carcinoma.

Drago F, Ciccarese G, Cogorno L, et al. Eur J Dermatol, 2017. PMID 28468736

2017 / Randomized controlled trial

High-fiber dietary advice reduced gastrointestinal toxicity during and after pelvic radiotherapy.

In a randomized trial, 166 patients receiving pelvic radiotherapy were assigned to low-fiber, habitual-fiber, or high-fiber dietary counseling. Although the primary endpoint of start-to-nadir bowel score changes did not differ significantly between groups (P = 0.093), high-fiber advice led to smaller score reductions from start to end of radiotherapy (-3.7 ± 12.8 vs -10.8 ± 13.5; P = 0.011). At 1 year, the high-fiber group maintained significantly better bowel scores than the habitual-fiber group (+0.1 ± 14.5 vs -8.4 ± 13.3; P = 0.004).

Wedlake L, Shaw C, McNair H, et al. Am J Clin Nutr, 2017. PMID 28679552

2016 / Dose-escalation feasibility trial

Fasting up to 72 hours around platinum-based chemotherapy was feasible and safe in cancer patients.

Researchers tested dose-escalation of fasting (24, 48, or 72 hours around chemotherapy) in 20 cancer patients receiving platinum-based regimens. Feasibility criteria were met, with fasting-related toxicities limited to grade 2 or lower (most commonly fatigue, headache, and dizziness). Leukocyte DNA damage showed a non-significant reduction in subjects fasting ≥48 hours (p = 0.08), and a non-significant trend toward less grade 3 or 4 neutropenia was observed in the 48 and 72 hour cohorts versus the 24 hour cohort (p = 0.17). IGF-1 levels decreased by 30%, 33%, and 8% in the 24, 48, and 72 hour fasting cohorts, respectively, after the first fasting period.

Dorff TB, Groshen S, Garcia A, et al. BMC Cancer, 2016. PMID 27282289

2016 / 4-arm randomized controlled trial

Caloric restriction with or without exercise significantly reduced circulating angiogenic biomarkers in overweight postmenopausal women.

A 12-month trial randomized 439 overweight/obese postmenopausal women to caloric restriction diet, aerobic exercise, combined diet + exercise, or control. Diet + exercise significantly reduced PAI-1 compared to control (-19.3% vs. +3.48%, P < 0.0001). Both the diet and combined arms showed significant reductions versus controls in PEDF (-9.20% and -9.90%, both P < 0.0001) and VEGF (-8.25%, P = 0.0005; -9.98%, P < 0.0001). Exercise alone produced no differences in any analyte versus control, while greater weight loss linearly correlated with larger biomarker reductions.

Duggan C, Tapsoba Jde D, Wang CY, et al. Cancer Res, 2016. PMID 27417562

2016 / Randomized controlled trial

Adding navy bean powder or rice bran was feasible, well tolerated, and significantly increased dietary fiber intake in colorectal cancer survivors.

Twenty-nine colorectal cancer survivors completed a randomized controlled trial receiving foods with cooked navy bean powder (35 g/day), heat-stabilized rice bran (30 g/day), or no added ingredient. The consumed amounts represented 4-9% of daily caloric intake, with no major gastrointestinal issues reported. Dietary fiber significantly increased in both the navy bean and rice bran groups at Weeks 2 and 4 compared with baseline and control (P <= 0.01). Telomere length correlated with age and HDL cholesterol at baseline, and with improved serum amyloid A levels at Week 4 (P <= 0.05).

Borresen EC, Brown DG, Harbison G, et al. Nutr Cancer, 2016. PMID 27689688

2015 / Randomized controlled crossover trial

Sulforaphane absorption was approximately three times higher from fresh broccoli sprouts than from a myrosinase-treated broccoli sprout extract.

Healthy adults consumed fresh broccoli sprouts or a myrosinase-treated broccoli sprout extract (BSE), each providing 200 μmol sulforaphane (SFN) daily, as a single dose or as two 100-μmol doses taken 12 hours apart. SFN metabolite levels measured by HPLC-MS/MS were approximately three-fold higher in plasma and urine after consuming fresh sprouts compared to BSE. Taking doses 12 hours apart maintained higher plasma SFN metabolite levels at later time points than single 24-hour dosing, but no dose responses were observed for molecular targets including heme oxygenase-1, histone deacetylase activity, or p21.

Atwell LL, Hsu A, Wong CP, et al. Mol Nutr Food Res, 2015. PMID 25522265

2015 / Randomized controlled trial

Green tea decreased prostate nuclear NFκB, systemic oxidation, and serum PSA before surgery.

In an open-label trial, 113 men with prostate cancer were randomized to consume six daily cups of brewed green tea, black tea, or water before radical prostatectomy; 93 finished the intervention. Proliferation, apoptosis, and tissue oxidation markers did not differ across groups. Green tea significantly decreased prostate tissue nuclear NFκB (p = 0.013), reduced urinary 8OHdG (p = 0.03), and modestly lowered serum PSA (p = 0.04) relative to control.

Henning SM, Wang P, Said JW, et al. Prostate, 2015. PMID 25545744

2015 / Phase I-II clinical trial

High-dose intravenous vitamin C was generally well tolerated alongside chemotherapy.

A phase I-II trial examined high-dose intravenous vitamin C added to chemotherapy in 14 patients with advanced cancer and limited treatment response expectations. The infusions were generally well tolerated, with only transient adverse events recorded. Pharmacokinetic analyses indicated higher tissue uptake of vitamin C following chemotherapy without increases in urinary oxalic acid. Three patients exhibited brief periods of stable disease and functional improvement.

Hoffer LJ, Robitaille L, Zakarian R, et al. PLoS One, 2015. PMID 25848948

2015 / Comparative exercise trial

A 6-month yoga program reduced percent body fat in breast cancer survivors but did not significantly alter inflammatory serum markers.

Breast cancer survivors participated in a six-month yoga-based exercise program (YE, n=20), with outcomes compared to a comprehensive exercise program and a self-chosen exercise comparison group. The YE group demonstrated significant decreases in % body fat (-3.00%, d = -0.44, p < .001), but showed no significant improvements in cardiorespiratory capacity or inflammatory markers (IL-6, IL-8, TNFα, and CRP). An ANCOVA controlling for baseline variables found no significant differences between groups and no significant changes in any inflammatory marker for any group.

Long Parma D, Hughes DC, Ghosh S, et al. Springerplus, 2015. PMID 25853030

2015 / Randomized controlled trial

Daily green tea catechins did not reduce one-year prostate cancer rates.

In a randomized, placebo-controlled trial, 97 men with high-grade prostatic intraepithelial neoplasia, atypical small acinar proliferation (ASAP), or both received either 400 mg daily EGCG from green tea catechins or a placebo for one year. One-year prostate cancer incidence did not differ significantly between arms (5 of 49 with catechins vs 9 of 48 with placebo, p = 0.25). The catechin group showed reduced serum PSA (-0.87 ng/mL, 95% CI -1.66 to -0.09).

Kumar NB, Pow-Sang J, Egan KM, et al. Cancer Prev Res (Phila), 2015. PMID 25873370

2015 / Randomized controlled trial

High-dose lycopene, selenium, and green tea catechins showed adverse trends in prostate lesions.

Sixty men with premalignant prostate lesions received daily lycopene (35 mg), selenium (55 µg), and green tea catechins (600 mg), or placebo for 6 months. At re-biopsy in 53 men, prostate cancer was diagnosed in 10 men in the supplement group versus 3 in the placebo group (p = 0.053). Supplementation was also associated with altered microRNA expression linked to cancer progression, while PSA levels and symptom scores showed no significant differences.

Gontero P, Marra G, Soria F, et al. Prostate, 2015. PMID 25893930